reason report
bottom line came away impress visionari
leadership solid execut rais pt
bi-annu i-day june high qualiti compound
continu along doubl digit growth trajectori across organ
inorgan driver top line coupl margin expans
medicaid privat pipelin consist track
record win continu recent fl az nm contract
expans medicaid purpl state va
growth adjac offer futur upsid core compet roll-
region plan hnt fide close june
envolv platform mitig peak margin risk hix
downgrad invest tech-en servic rx advanc
interpreta showcas promin event strengthen cnc
industri lead medic cost manag modestli rais
revenu estim reflect guidanc updat maintain ep
tx contract award oct lead
incumb share potenti binari event driven risk
media report around network adequaci though like manag
balanc sheet debt cap rate upgrad
still invest grade impact bond issuanc
fide new pt contempl price-to-earnings
i-day impress vision mission driven leadership
execut michael neidorff team addit
usual busi updat growth pipelin technolog panel
showcas rxadvanc cloud-bas pbm interpreta clinic
decis support manag time basi cnc strateg
invest addit envolv medic cost manag
clearli exemplari year solid contract win
success integr hnt close fide strateg invest
technolog enabl servic rxadvanc interpreta
reward handsom valuat impress
mix busi becom diversifi geograph
across state also busi segment perspect
non-medicaid busi increas
impress track record contract win continu pipelin
 across contract though tx modest binari event
risk award expect noteworthi contract win fl
az nm
net debt total capit
price-to-earnings lt ep growth
ep
gener long term ep growth period
compani inform leerink partner llc research
revenu billion adj ep
pleas refer page analyst certif import disclosur price chart disclosur specif
cover compani statement valuat risk avail
manag remain bullish exchang mm
member repres revenu earn
repeal individu mandat seen impact given
hix member subsid recent doj brief elimin
provis guarante issu commun rate regardless pre-
exist condit seen uncertain materi like take
long time given lengthi court process
success roll-up fide hnt envolv platform
chang invest thesi view see accret
consolid platform play mitig downsid risk
peakish exchang mm member margin rate
downgrad manag see elimin cross walk
present immateri downsid though estim potenti
subject share upsid provid
technology-en servic rx advanc interpreta
showcas interest time panel manag
particip use case mitig opioid abus john
sculley chairman ravi ika presid ceo rxadvanc
posit asset disrupt cloud base platform pbm compani
differenti analog model op esrx mp
 even optum rx dr ahm ghouri ceo interpreta dr ken
yamaguchi showcas asset use case opioid
abus envolv remain impress medic cost manag across
usmm primari care home health platform casenet
hous pbm acadia manag expect transit
rxadvanc time own physician target
approach certain state boost network adequaci rather broad
revenu in-lin guidanc
 modestli rais revenu reflect
new guidanc maintain ep
respect ep guidanc exclud ca
medicaid expans headwind mm mid-
point ep though retroact compani expect ep downsid
immateri revenu guidanc offer event
consensu though margin guidanc offer
dec i-day consist prior practic downgrad
state present immateri downsid
balanc sheet post fide reflect debt capit
recent rate upgrad still fall short invest grade
impact recent bond issuanc post fide
pt goe repres price-to-earnings ep
agenda featur strateg overview ceo michael neidorff detail financi
updat review market product oper intern busi
leadership team panel focus technolog featur leader
interpreta rxadvanc
breakfast registr
cynthia brinkley chief administr market offic
panel transform healthcar technolog
ravi ika presid ceo rxadvanc
john sculley chairman chief market offic rxadvanc
leverag system improv member health
ny approv clear way fide deal close juli
posit market leader revenu largest medicaid market ca
tx fl ny health plan also lead la ks mo ms ne
seen continu success rfp perform past sever year
win rate sinc investor day leadership provid detail re-procur win
expans new market futur growth pipelin
re-procur az contract plan arizona complet health integr behavior
health physic health plan one product select maximum allow
region membership az estim member revenu estim
remain current level go-liv schedul also re-procur fl
busi via subsidiari sunshin health select provid mma long-term care
servic statewid previous serv mma region long-term care
region addit membership estim member contract go-
live date
also statewid rfp nm ia nm plan western commun
provid tanf ssi long-term care behavior health servic estim
member elig start new ia contract start
plan iowa total project serv member across medicaid
popul also submit nc new medicaid program anticip go-liv
leadership identifi target pipelin built also bullish
growth prospect beyond alreadi contract manag care continu grow
state-by-st across countri medicaid spend still fee-for-servic
nearli lie cnc market alreadi add half remain outsid
cnc market manag care state pipelin move forward come
lead medicaid market exclud ny enter fide market leader
enjoy continu rfp success far renew contract fl az
ad new state nm ia wa
compil june investor day present
beyond target pipelin view futur growth pipelin medicaid
manag combin ff spend market ff spend
state manag total
continu commit hix medicar advantag
continu commit hix medicar advantag segment
shown signific growth despit uncertainti around hix market viabil margin well
headwind relat rate
total hix enrol mm across state includ enrol new state ks
mo nv ny upward growth retent previou year
lowest cost silver plan counti oper
hix market impact uncertainti around polici decis sinc incept
recent repeal individu mandat doj brief elimin provis
guarante issu commun rate regardless pre-exist condit lack csr fund
addit short-term limit durat plan top mind investor
believ repeal individu mandat factor given
hix member subsid believ decis regard elimin provis
popular pre-exist condit requir would take long time court face broad
lack csr fund result slight increas bronz enrol correspond
decreas silver enrol though note demograph remain consist
year year
believ recent introduct plan execut order
materi impact enrol given plan provid far better valu target market
larg subsid fpl
medicar segment project member revenu includ
fide membership total enrol expect exceed growth target
believ core group d-snp project enrol lay foundat futur
acknowledg headwind creat recent downgrad reiter
one-year issu address polici perspect perform
perspect adjust regul go forward undertak broad
improv initi correct action reveal cross-walk applic
defer declin share financi impact downplay
de minimi one-year impact back normal
cnc hix enrol continu climb mm though lack csr may
view short-term limit durat plan materi threat enrol
provid valu member fpl
think may recal elimin preexist condit alway popular part nation poll broader implic see thing work result result believ extrem well-posit move forward marketplac product futur growth profit mani reason -kevin counihan senior vice presid product centen corpor
estim cnc hix revenu ep exposur respect
grown medicar membership member leadership
point d-snip popul project potenti futur growth driver
hix membership annual revenu mm pmpm exposur guidanc pre-tax hix pre-tax incom rate guidanc hix net incom count guidanc mid-point hix ep contribut exposur guidanc exposur centen corpor
despit elimin cross-walk leadership remain steadfast cnc rate
headwind littl materi impact perform
part diversif strategi identifi opportun leverag expertis
manag care data analyt govern partnership new market around world
far uk spain focus five area servic advisori servic
integr care care coordin advanc improv care qualiti manag full-risk
trend seen us also manifest global china expect add
hospit bed world popul project
compar today begun work spain uk begin bring market
expertis bear uk affili help integr fragment care market bring
togeth dispar part system hospit regul patient spain cnc
joint ventur ribera salud implement cnc casenet subsidiari care manag
program improv care coordin creat person care plan patient
within ribera salud network ribera salud lead lab provid madrid also
oper primari care center univers hospit cover citizen valencia
ribera salud fulli capit cnc invest technolog integr care model
lower cost versu previou oper model
view health challeng similar around world begun bring expertis
manag data analyt govern partnership patient uk spain
coordin advanc technolog qualiti improv manag full-risk
signific invest technolog home-grown minor stake
becom hcit start-up sort develop tool reduc cost improv
provid detail rxadvanc interpreta two recent technolog invest
believ potenti signific driver growth margin expans
futur rxadvanc full servic cloud-bas pbm platform uniqu posit streamlin
pbm ecosystem drive drug cost increas complianc reduc wast
interpreta perform continu real-tim clinic interpret member health data better
coordin care identifi coverag gap integr tool provid interpreta
continu leverag uniqu govern experi expertis posit trust strateg partner around world view earli invest platform launch market around world -cynthia brinkley chief administr market offic corpor
rxadvanc homegrown tech-en coordin care platform casenet
drive cost improv outcom
march made minor invest rxadvanc invest brought two
engag execut john sculley chairman board ravi ika presid
ceo tent john sculley excel track record act ceo
presid pepsi-cola found investor multipl success startup
includ metropc sold t-mobil ralli health sold
believ rxadvanc platform offer multipl advantag tradit pmb
model includ simplifi cloud-bas platform access across continuum care
payer provid built ground-up robot process autom
major administr grunt work person touch ad valu
john sculley believ rxadvanc significantli differenti pbm cloud pbm abl take data across entir continuum care one els amaz got involv rxadvanc saw technolog everi pbm use hardwir way take data across entir care continuum look join strateg rxadvanc centen saw unitedhealthcar built optum optum analog optum peopl intens take platform abl intact across entir care continuum make advanc differ pbm centen corpor
still earli day time expect migrat intern develop pbm
vertic rxadvanc platform certain capabl legaci pbm
better rxadvanc pharmaci manag retain function
administr function prior author taken rxadvanc current
four plan transit plan come on-board compani expect
plan migrat addit rxadvanc continu serv outsid
rxadvanc well-pois tackl drug-bas medic wast rxadvanc
track high risk patient elimin advers drug event point care streamlin
prescript deliveri improv adher vital sign monitor
invest interpreta realiz need close align provid payer
improv member outcom interpreta rapidli integr data dispar health sourc
develop real-tim treatment roadmap patient
interpreta system allow doctor plan ahead provid real time data aggreg
interpret across multipl user numer system dramat reduc gap care
enabl inform coordin interpret across provid
opioid crisi disproport affect medicaid popul accord kaiser
foundat medicaid cover nonelderli adult opioid addict brought
uniqu tech-en solut bear help stem crisi machin learn
data analyt tool compani develop score determin risk opioid abus call
orca score akin credit score put place specif polici around
member proactiv reduc risk abus morphin equival dose per day cap
also use commun base tool inform booklet effect commun
member
seen tangibl result program reduct opioid prescript
importantli decreas opioid util drug day
revenu in-lin guidanc modestli
rais revenu reflect new guidanc
maintain ep respect ep
guidanc exclud ca medicaid expans headwind mm
mid-point ep though retroact
compani expect ep downsid immateri revenu guidanc offer
event consensu though margin guidanc offer dec
i-day consist prior practic downgrad state present immateri
revenu guid howev in-lin prior practic guidanc
dec feb april june dayleerink estim -newconsensu estimatestot revenu expens ratio expens ratio excl acquisit relat tax share outstand compani guidanc centen corpor
maintain ep estim modestli rais revenu estim
membership cnc rate
decreas
reportedconsensusleerink newconsensusleerink newrevenu incom non-gaap growth ratingscnc membership rate ratingscnc membership rate centen corpor
howev manag expect minim impact
updat star
mani know star polici polici issu larg correct current call letter howev also star perform issu respons correct correct mani process correct cross-walk applic defer decis de minimi impact focus broadli correct system issu impact star rank first place kevin counihan sr -product centen corp i-day centen corpor
balanc sheet post fide reflect debt capit recent rate
upgrad still fall short invest grade impact recent bond issuanc
debt cap estim reflect capit rais fide transact
pt contempl price-to-earnings ep
primari valuat methodolog base rel price-to-earnings rel price-to-earnings
track function compani histori manag group averag assess
potenti price-to-earnings expans next month base forward forecast
contempl underli fundament implic healthcar reform dcf valuat
leverag forward forecast wacc termin growth rate inform
potenti multipl expans along sector compani specif catalyst expect
greater potenti multipl expans dcf valuat point significantli upsid
peer current trade level
free cash flow yield ratio also inform potenti multipl expans
except low ratio and/or high free cash flow yield point potenti greater
multipl expans use absolut rel price-to-earnings multipl base approach valuat
ep estim combin price-to-earnings base approach dcf model point
intrins valu compani plu add premium deal probabl
price target repres price-to-earnings ep
downsid risk invest thesi valuat aet legisl regulatori
polici chang could either dis-intermedi health insur us benefit
marketplac place unforeseen top-lin margin headwind commerci medicar
advantag medicaid dual elig book busi not-for-profit health insur
price irrat commerci health benefit marketplac acceler employ exit
sponsorship health benefit us marketplac post implement
afford act advers select public exchang protect adequ
given delay true-up govern payment acquisit asset
without attract return capit investor organiz and/or oper risk
lead execut mis-step downsid risk earn
upsid risk invest thesi valuat aet accret acquisit
aggress share repurchas use solid parent cash posit debt rais
primari valuat methodolog base rel price-to-earnings rel price-to-earnings
track function compani histori manag group averag assess
potenti price-to-earnings expans next month base forward forecast
contempl underli fundament implic healthcar reform
dcf valuat leverag forward forecast wacc termin growth rate
inform potenti multipl expans along sector compani specif catalyst
expect greater potenti multipl expans dcf valuat point significantli
upsid peer current trade level free cash flow yield ratio also inform
potenti multipl expans except low ratio and/or high free cash flow yield
point potenti greater multipl expans
new pt contempl price-to-earnings ep
risk invest thesi valuat
legisl regulatori polici chang could either dis-intermedi
insur us benefit marketplac place unforeseen top-lin margin
headwind commerci medicar advantag medicaid dual elig book
not-for-profit health insur price irrat commerci health benefit
acceler employ exit sponsorship health benefit us
marketplac post implement afford act
advers select public exchang protect adequ given delay
true-up govern payment
acquisit asset without attract return capit investor
organiz and/or oper risk drive execut mis-step downsid risk
earn
primari valuat methodolog base rel price-to-earnings rel price-to-earnings
track function compani histori manag group averag assess
potenti price-to-earnings expans next month base forward forecast
contempl underli fundament implic healthcar reform dcf valuat
leverag forward forecast wacc termin growth rate inform
potenti multipl expans along sector compani specif catalyst expect
greater potenti multipl expans dcf valuat point significantli upsid
peer current trade level free cash flow yield ratio also inform
potenti multipl expans except low ratio and/or high free cash flow yield
point potenti greater multipl expans
base price-to-earnings multipl appli stand-alone ep rate ci
outperform price target
non-profit bcb plan insur price irrat commerci market rapidli
medic cost trend come higher anticip potenti econom downturn
provid re-up intens servic deliveri cobra acceler uptak
member util care advanc layoff pandem
employ exit rapidli sponsorship health benefit combat medic cost
inflat catalyz econom downturn
risk declin invest yield invest impair
state-bas actuari rate review limit sound price underwrit caus
longer term state-bas insur exchang advers select reduc
sustain earn power employ dump employe health insur
exchang signific margin compress potenti downsid membership
polit shock lead singl payer
compani specif risk signific declin equiti market could result increas fund
compani pension oblig polit legal oper regulatori econom
risk foreign oper
dcf valuat leverag forward forecast wacc termin growth rate
inform potenti multipl expans along sector compani specif catalyst
expect greater potenti multipl expans dcf valuat point significantli
upsid peer current trade level free cash flow yield ratio also inform
potenti multipl expans except low ratio and/or high free cash flow yield
point potenti greater multipl expans price target base case
ep estim
risk valuat includ
start-up cost underwrit issu associ new busi on-board
particularli challeng new popul dual elig
annual off-cycl rate chang state medicaid program
uncertainti associ competit bid process state
legisl regulatori judici polici chang medicaid entitl program
state feder suprem court level also risk consid
remain posit reiter op rate month pt
contempl price-to-earnings ep
risk invest thesi valuat legisl regulatori
polici chang could either dis-intermedi health insur us benefit
marketplac place unforeseen top-lin margin headwind commerci medicar
advantag medicaid dual elig book busi not-for-profit health insur
price irrat commerci health benefit marketplac acceler employ exit
sponsorship health benefit us marketplac post implement
afford act advers select public exchang protect adequ
given delay true-up govern payment acquisit asset
without attract return capit investor organiz and/or oper risk
lead execut mis-step downsid risk earn acceler medic cost
trend util improv economi
pt reflect price-to-earnings ep
start-up cost underwrit issu associ new busi on-board
particularli challeng new popul dual elig
annual off-cycl rate chang state medicaid program
uncertainti associ competit bid process state
legisl regulatori judici polici chang medicaid
scale issu result loss specialti rx pharmaci contract
acquisit offer adequ return capit
upsid takeout substanti premium key risk
carve-out behavior health servic current state contract
primari valuat methodolog base rel price-to-earnings rel price-to-earnings
track function compani histori manag group averag assess
potenti price-to-earnings expans next month base forward forecast
contempl underli fundament implic healthcar reform
primari valuat methodolog base rel price-to-earnings rel price-to-earnings
track function compani histori manag group averag assess
potenti price-to-earnings expans next month base forward forecast
contempl underli fundament implic healthcar reform
dcf valuat leverag forward forecast wacc termin growth rate
inform potenti multipl expans along sector compani specif catalyst
expect greater potenti multipl expans dcf valuat point significantli
upsid peer current trade level
free cash flow yield ratio also inform potenti multipl expans
except low ratio and/or high free cash flow yield point potenti greater
base post month turnaround rate outperform pt
contempl price-to-earnings ep
risk highlight first spike util on-board new state contract
dual elig integr second state-bas insur exchang result advers
select reduc sustain earn power third state-bas contract rate increas
suffici cover medic trend off-set industri fee medicaid premium fourth risk re-
procur exist contract could creat substanti downsid risk volatil fifth
legisl judici risk manag medicaid entitl extrem case singl
payer model also possibl downsid
primari valuat methodolog base rel price-to-earnings rel price-to-earnings
track function compani histori manag group averag assess
potenti price-to-earnings expans next month base forward forecast
contempl underli fundament implic healthcar reform
dcf valuat leverag forward forecast wacc termin growth rate
inform potenti multipl expans along sector compani specif catalyst
expect greater potenti multipl expans dcf valuat point significantli
upsid peer current trade level
free cash flow yield ratio also inform potenti multipl expans
except low ratio and/or high free cash flow yield point potenti greater
rate outperform price target contempl price-to-earnings
cash ep
non-profit bcb plan insur price irrat commerci market rapidli
medic cost trend come higher anticip potenti double-dip recess
provid re-up intens servic deliveri cobra acceler uptak member util
care advanc lay-off pandem
employ exit rapidli sponsorship health benefit combat medic cost
inflat catalyz double-dip recess
risk declin invest yield invest impair
state-bas actuari rate review limit sound price underwrit caus substanti
long-term state base health insur exchang advers select reduc
sustain earn power employ dump employe health insur
exchang signific margin compress also potenti downsid membership
risk relat collect industri fee medicar medicaid premium
polit shock lead singl payer
compani specif risk downsid risk price target includ acquisit asset
arena yield adequ return capit
primari valuat methodolog base rel price-to-earnings rel price-to-earnings
track function compani histori manag group averag assess
potenti price-to-earnings expans next month base forward forecast
contempl underli fundament implic healthcar reform
dcf valuat leverag forward forecast wacc termin growth rate
inform potenti multipl expans along sector compani specif catalyst
expect greater potenti multipl expans dcf valuat point significantli
upsid peer current trade level
free yield ratio also inform potenti multipl expans
except low ratio and/or high free yield point potenti greater
base rate wcg outperform pt contempl price-to-earnings
ep
downsid risk price target includ execut new state contract dual elig
award rate increas suffici cover medic trend state clawback tax off-set tax
reform tailwind potenti dial medicaid expans ky upsid risk price
target includ take-out larger player
centen corpor incom statement except oper tax health insur sale firstguard cnc-hnt transact incom net incom net averag share ep dilut growth net profit growth centen corpor
